Cue Biopharma

CUE · NASDAQ

$17.04+$0.96 (+5.97%)TodayMarket closed ·
Prev close $16.08

Who owns CUE

Largest institutional holders, from their latest 13F filings

The 10 largest institutions hold 42.0% of CUE’s shares.

  • Lin (Shao-Lee)9.4%
  • Bleichroeder LP9.2%
  • Driehaus Capital Management, LLC7.2%
  • Vanguard Capital Management, LLC4.0%
  • Next 6 largest institutions12.2%
  • All other shareholders58.0%
Top institutional holders of CUE
HolderShares% of shares
Lin (Shao-Lee)380.67K9.40%
Bleichroeder LP370.68K9.15%
Driehaus Capital Management, LLC292.14K7.21%
Vanguard Capital Management, LLC161.70K3.99%
Ray (Sumita J.D.)118.55K2.93%
Ikarian Capital LLC104.36K2.58%
Polygon Management Ltd.93.82K2.32%
StemPoint Capital LP67.00K1.65%
BlackRock Institutional Trust Company, N.A.56.98K1.41%
Adar1 Capital Management LLC55.19K1.36%

Largest mutual fund holders

Top mutual fund holders of CUE
HolderShares% of shares
Vanguard Total Stock Market Index Fund111.87K2.76%
Vanguard Extended Market Index Fund47.09K1.16%
Fidelity Extended Market Index Fund19.84K0.49%
iShares Micro-Cap ETF11.28K0.28%
Fidelity Total Market Index Fund7.25K0.18%

Insider trades

Form 4 filings by officers, directors and large holders

Over the last 6 months, insiders bought $999.97K (1 trade) and sold $2.43M (15 trades) of CUE on the open market.

Latest CUE insider transactions
InsiderTypeSharesValue
Meluzio Michael VincentSale1.14K$32.09K
Lin Shao-LeeSale1.09K$30.49K
Lin Shao-LeeSale10.00K$275.00K
Ray SumitaSale1.84K$51.72K
Meluzio Michael VincentOption exercise13.65K—
Meluzio Michael VincentSale3$93
Meluzio Michael VincentSale4.11K$124.62K
Meluzio Michael VincentSale1.52K$44.61K
Meluzio Michael VincentOption exercise13.65K—
Ray SumitaOption exercise18.20K—

Short interest

Settled Sep 30, 2026

Shares short
702.20K
Days to cover
1.05
% of shares outstanding
17.34%
Average daily volume
666.08K
Change since last report
+111.4%

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.